CID 11035494

Semiglabrinol

Structural Information

Molecular Formula
C21H18O5
SMILES
CC1([C@@H]([C@@H]2[C@H](O1)OC3=C2C4=C(C=C3)C(=O)C=C(O4)C5=CC=CC=C5)O)C
InChI
InChI=1S/C21H18O5/c1-21(2)19(23)17-16-14(25-20(17)26-21)9-8-12-13(22)10-15(24-18(12)16)11-6-4-3-5-7-11/h3-10,17,19-20,23H,1-2H3/t17-,19-,20+/m1/s1
InChIKey
XBKLVCYSINXGAW-RLLQIKCJSA-N
Compound name
(12S,15R,16R)-15-hydroxy-14,14-dimethyl-4-phenyl-3,11,13-trioxatetracyclo[8.6.0.02,7.012,16]hexadeca-1(10),2(7),4,8-tetraen-6-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

350.11542 Da
Monoisotopic Mass

2.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 351.12270 178.3
[M+Na]+ 373.10464 190.0
[M-H]- 349.10814 189.9
[M+NH4]+ 368.14924 195.8
[M+K]+ 389.07858 188.0
[M+H-H2O]+ 333.11268 173.5
[M+HCOO]- 395.11362 194.7
[M+CH3COO]- 409.12927 191.1
[M+Na-2H]- 371.09009 182.0
[M]+ 350.11487 184.1
[M]- 350.11597 184.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.